SCIEX has announced that Aarhus University Hospital in Denmark has invested in SCIEX QTRAP® 6500 technology to develop novel mass spectrometry-based assays for clinical research laboratories. Scientists at the hospital’s Department of Clinical Biochemistry are using the QTRAP 6500 LC-MS/MS system for advanced clinical research.
LC-MS/MS based methods are highly sensitive and achieve extremely low limits of detection, thus overcoming the performance of some immunoassays limited by interference issues. “The advantages of using the QTRAP 6500 for our research are that it has extremely good selectivity and sensitivity; it produces exceptionally reliable results as well as providing the highest uptime,” said Carsten Schriver Højskov, Aarhus University Hospital. The laboratory now has two SCIEX 5500 systems, four SCIEX QTRAP 6500 systems and a TripleTOF® 5600 instrument.
“We have always had a good experience with SCIEX instruments and we have received excellent service from the company through collaboration with their application specialists,” added Carsten Schriver Højskov.